A LifeSign Status BTA is available in either boxes of 10 or 25 tests.

Designed for the detection of bladder tumor associated antigens in human urine of patients diagnosed with bladder cancer, a LifeSign Status BTA provides rapid results that are ready in as few as five minutes. Also detects early stage recurrence cancer that cytology may miss and provides the most accurate test results possible thanks to superior sensitivity and specificity.

Features

LifeSign Status BTA Features

• CLIA waived.
• Designed to be used as an aid in the monitoring of bladder cancer patients in conjunction with cystocospy.
• Detects early stage recurrence cancer that cytology may miss.
• Simple procedure - just add three drops of urine to the test device (no sample preparation needed).
• Provides accurate test results thanks to superior sensitivity and specificity.
• Results are ready within five minutes.

Quantity

LifeSign Status BTA Quantity

• 10 (#LFS-39010).
• 25 (#LFS-39025).

Accessories

LifeSign Status BTA Accessories

• LifeSign Uricult CLED/EMB (#LFS-1000).
• LifeSign Uricult CLED/Polymyxin/EMB (#LFS-1002).
• LifeSign Uricult CLED/Polymyxin/MacConkey (#LFS-1003).
• LifeSign Cultura M Incubator (#LFS-05866).
• LifeSign Status BTA Control Set - POS & NEG (#LFS-200019).

Literature

LifeSign Status BTA Literature

LifeSign Status BTA Package Insert

LifeSign Status BTA Patient Instructions

LifeSign BTA Control SDS

LifeSign BTA Sell Sheet